10x Genomics Stock (NASDAQ: TXG) stock price, news, charts, stock research, profile.
Open | $30.960 |
Close | $29.160 |
Volume / Avg. | 3.063M / 1.368M |
Day Range | 29.120 - 31.140 |
52 Wk Range | 30.300 - 63.570 |
Market Cap | $3.216B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 20 |
Short Interest | 10.16% |
Days to Cover | 6.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of 10x Genomics (NASDAQ: TXG) through any online brokerage.
Other companies in 10x Genomics’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), Waters (NYSE:WAT), Sotera Health (NASDAQ:SHC) and Olink Holding (NASDAQ:OLK).
The latest price target for 10x Genomics (NASDAQ: TXG) was reported by Barclays on Wednesday, April 10, 2024. The analyst firm set a price target for 45.00 expecting TXG to rise to within 12 months (a possible 66.73% upside). 18 analyst firms have reported ratings in the last year.
The stock price for 10x Genomics (NASDAQ: TXG) is $26.99 last updated April 17, 2024 at 7:57 PM EDT.
There are no upcoming dividends for 10x Genomics.
10x Genomics’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for 10x Genomics.
10x Genomics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.